Compliance SweepBack to stories →
← Back to stories
Governance & business operationsNew in this edition

DEA raises 2026 production quotas for hydromorphone, amphetamine and methylphenidate after FDA shortage reports

The Drug Enforcement Administration (DEA) issued a final order, effective November 10, 2026, raising the 2026 aggregate production quotas (APQ) for d,l-amphetamine, d-amphetamine (for sale), hydromorphone and methylphenidate (for sale). For hydromorphone, DEA found that multiple manufacturers had reported a domestic shortage of hydromorphone hydrochloride injectable products, and it raised the APQ from 1,949,378 grams to 2,356,798 grams. DEA published the order without a comment period to meet the 30-day review timeframe for schedule II drugs on the Food and Drug Administration (FDA) shortage list.

Background

DEA sets yearly production quotas for schedule I and II controlled substances, and it published the established 2026 quotas on January 5, 2026 (91 FR 287). When a manufacturer asks for more quota for a schedule II drug on FDA's shortage list, the law requires DEA to complete its review within 30 days.

Who this affects

Hospital pharmacies and supply chain teams managing hydromorphone injectable and stimulant shortages.

Why it matters

Inference: more quota allows manufacturers to make more hydromorphone, which may ease the injectable shortage over time; it does not by itself restore supply, so hospital shortage protocols and substitution plans stay in place.

Scope and timing

Authority status
Final
Responsible owner
Pharmacy; Supply Chain
Publication date
2026-11-10
Effective date
2026-11-10
Other dates
Signed 2026-11-04; issued without a comment period

Not established

Current FDA shortage status for hydromorphone injection was not checked.

Sources

Complete edition and supplemental material

This article in the complete report →

Executive triage, source-coverage limitations, context and forward horizons remain in the complete report.

Read the entire Compliance Sweep report →

← Return to stories

Privacy preferences

Where enabled for this site, Cloudflare Web Analytics can send page-use and performance measurements to Cloudflare. This panel provides information and does not turn analytics on or off.

This panel stores no tracking choice and does not change your tool saves, screening, resets, reports or exports. Other sites have separate settings.

Read Privacy & Cookies